target-话题@MedSci

#target#

230篇内容 | 1212人围观

关注话题

话题活跃用户

#插入话题

插入图片

最新最热

[GetTopicListResponse(id=1795526, encodeId=3d4f1e95526ae, content=<a href='/topic/show?id=248e1e1345b' target=_blank style='color:#2F92EE;'>#target#</a>, objectTitle=Signal Transduct Target Ther：人脐带血间充质干细胞治疗银屑病, objectType=article, longId=735899, objectId=a42fe35899ec, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=a42fe35899ec, replyNumber=0, likeNumber=44, createdTime=2022-09-06, rootId=0, userName=闆锋旦, userId=8409354, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=a42fe35899ec, moduleTitle=Signal Transduct Target Ther：人脐带血间充质干细胞治疗银屑病, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=a42fe35899ec)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1795521, encodeId=99241e9552169, content=<a href='/topic/show?id=248e1e1345b' target=_blank style='color:#2F92EE;'>#target#</a>, objectTitle=Target Oncol:FLAURA中国研究表明一线奥希替尼治疗较吉非替尼改善中国人群EGFR突变NSCLC患者的预后, objectType=article, longId=295592, objectId=e4e3295592aa, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=e4e3295592aa, replyNumber=0, likeNumber=59, createdTime=2022-07-11, rootId=0, userName=闆锋旦, userId=8409354, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=e4e3295592aa, moduleTitle=Target Oncol:FLAURA中国研究表明一线奥希替尼治疗较吉非替尼改善中国人群EGFR突变NSCLC患者的预后, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=e4e3295592aa)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1795525, encodeId=19291e95525b1, content=<a href='/topic/show?id=248e1e1345b' target=_blank style='color:#2F92EE;'>#target#</a>, objectTitle=Target Oncol:真实世界评估阿比特龙+泼尼松或泼尼松龙(AAP)一线或二线治疗转移性去势抵抗前列腺癌(mCRPC)的疗效和安全性, objectType=article, longId=299289, objectId=97bb29928916, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=97bb29928916, replyNumber=0, likeNumber=65, createdTime=2022-12-30, rootId=0, userName=闆锋旦, userId=8409354, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=97bb29928916, moduleTitle=Target Oncol:真实世界评估阿比特龙+泼尼松或泼尼松龙(AAP)一线或二线治疗转移性去势抵抗前列腺癌(mCRPC)的疗效和安全性, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=97bb29928916)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1795527, encodeId=481f1e9552702, content=<a href='/topic/show?id=248e1e1345b' target=_blank style='color:#2F92EE;'>#target#</a>, objectTitle=Signal Transduct Target Ther：研究揭示人脐带间充质干细胞治疗银屑病的疗效及机制, objectType=article, longId=736656, objectId=cfb1e3665671, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=cfb1e3665671, replyNumber=0, likeNumber=62, createdTime=2022-11-05, rootId=0, userName=闆锋旦, userId=8409354, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=cfb1e3665671, moduleTitle=Signal Transduct Target Ther：研究揭示人脐带间充质干细胞治疗银屑病的疗效及机制, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=cfb1e3665671)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1795524, encodeId=b4c71e9552432, content=<a href='/topic/show?id=248e1e1345b' target=_blank style='color:#2F92EE;'>#target#</a>, objectTitle=Target Oncol:评估真实世界中符合和不符合AURA3研究标准患者二线使用奥希替尼治疗的疗效, objectType=article, longId=295710, objectId=a635295e103b, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=a635295e103b, replyNumber=0, likeNumber=55, createdTime=2022-12-19, rootId=0, userName=闆锋旦, userId=8409354, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=a635295e103b, moduleTitle=Target Oncol:评估真实世界中符合和不符合AURA3研究标准患者二线使用奥希替尼治疗的疗效, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=a635295e103b)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1795518, encodeId=3eae1e955188d, content=<a href='/topic/show?id=248e1e1345b' target=_blank style='color:#2F92EE;'>#target#</a>, objectTitle=Signal Transduct Target Ther：人脐带间充质干细胞治疗COVID-19患者的安全性如何？, objectType=article, longId=212667, objectId=ec9b21266e90, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=ec9b21266e90, replyNumber=0, likeNumber=46, createdTime=2021-07-18, rootId=0, userName=闆锋旦, userId=8409354, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=ec9b21266e90, moduleTitle=Signal Transduct Target Ther：人脐带间充质干细胞治疗COVID-19患者的安全性如何？, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=ec9b21266e90)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1795523, encodeId=a8091e9552377, content=<a href='/topic/show?id=248e1e1345b' target=_blank style='color:#2F92EE;'>#target#</a>, objectTitle=Target Oncol:真实世界探索Crizotinib（克唑替尼）治疗ROS1阳性晚期非小细胞肺癌（NSCLC）患者的疗效, objectType=article, longId=295679, objectId=7f802956e901, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=7f802956e901, replyNumber=0, likeNumber=55, createdTime=2022-07-10, rootId=0, userName=闆锋旦, userId=8409354, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=7f802956e901, moduleTitle=Target Oncol:真实世界探索Crizotinib（克唑替尼）治疗ROS1阳性晚期非小细胞肺癌（NSCLC）患者的疗效, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=7f802956e901)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1795522, encodeId=c0301e95522b4, content=<a href='/topic/show?id=248e1e1345b' target=_blank style='color:#2F92EE;'>#target#</a>, objectTitle=Target Oncol:吴一龙教授IIIb期研究关注近真实世界中afatinib(阿法替尼)治疗EGFR突变阳性NSCLC患者的疗效, objectType=article, longId=295658, objectId=04a8295658c9, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=04a8295658c9, replyNumber=0, likeNumber=33, createdTime=2022-05-03, rootId=0, userName=闆锋旦, userId=8409354, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=04a8295658c9, moduleTitle=Target Oncol:吴一龙教授IIIb期研究关注近真实世界中afatinib(阿法替尼)治疗EGFR突变阳性NSCLC患者的疗效, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=04a8295658c9)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1795520, encodeId=035b1e9552057, content=<a href='/topic/show?id=248e1e1345b' target=_blank style='color:#2F92EE;'>#target#</a>, objectTitle=Signal Transduct Target Ther：PD-1抑制剂Toripalimab（特瑞普利单抗）联合化疗二线治疗晚期EGFR突变NSCLC一线TKI进展后显示良好抗肿瘤疗效和可控安全性, objectType=article, longId=293109, objectId=d234293109ad, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=d234293109ad, replyNumber=0, likeNumber=43, createdTime=2022-01-29, rootId=0, userName=闆锋旦, userId=8409354, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=d234293109ad, moduleTitle=Signal Transduct Target Ther：PD-1抑制剂Toripalimab（特瑞普利单抗）联合化疗二线治疗晚期EGFR突变NSCLC一线TKI进展后显示良好抗肿瘤疗效和可控安全性, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=d234293109ad)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1795519, encodeId=fe3d1e95519b0, content=<a href='/topic/show?id=248e1e1345b' target=_blank style='color:#2F92EE;'>#target#</a>, objectTitle=miRNA-34a decreases ovarian cancer cell proliferation and chemoresistance by targeting HDAC1, objectType=article, longId=220880, objectId=1f00220880cb, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=1f00220880cb, replyNumber=0, likeNumber=49, createdTime=2022-05-08, rootId=0, userName=闆锋旦, userId=8409354, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=1f00220880cb, moduleTitle=miRNA-34a decreases ovarian cancer cell proliferation and chemoresistance by targeting HDAC1, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=1f00220880cb)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1795517, encodeId=5c211e9551754, content=<a href='/topic/show?id=248e1e1345b' target=_blank style='color:#2F92EE;'>#target#</a>, objectTitle=Signal Transduct Target Ther.：治疗慢性疼痛的新发现, objectType=article, longId=212392, objectId=6f8b21239225, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=6f8b21239225, replyNumber=0, likeNumber=35, createdTime=2022-01-04, rootId=0, userName=闆锋旦, userId=8409354, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=6f8b21239225, moduleTitle=Signal Transduct Target Ther.：治疗慢性疼痛的新发现, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=6f8b21239225)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1795516, encodeId=bc301e9551691, content=<a href='/topic/show?id=248e1e1345b' target=_blank style='color:#2F92EE;'>#target#</a>, objectTitle=Lancet Neurology：急性缺血性卒中（BP-TARGET）血管内治疗成功后强化降压的安全性和有效性：一项多中心、开放标签、随机对照试验, objectType=article, longId=209639, objectId=abf82096395a, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=abf82096395a, replyNumber=0, likeNumber=50, createdTime=2021-07-08, rootId=0, userName=闆锋旦, userId=8409354, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=abf82096395a, moduleTitle=Lancet Neurology：急性缺血性卒中（BP-TARGET）血管内治疗成功后强化降压的安全性和有效性：一项多中心、开放标签、随机对照试验, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=abf82096395a)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1795514, encodeId=19871e955140a, content=<a href='/topic/show?id=248e1e1345b' target=_blank style='color:#2F92EE;'>#target#</a>, objectTitle=Signal Transduct Target Ther：浙大蔡秀军团队揭示外泌体介导的肝癌靶向耐药细胞间传播新机制, objectType=article, longId=205115, objectId=c5d42051150b, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=c5d42051150b, replyNumber=0, likeNumber=45, createdTime=2021-01-24, rootId=0, userName=闆锋旦, userId=8409354, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=c5d42051150b, moduleTitle=Signal Transduct Target Ther：浙大蔡秀军团队揭示外泌体介导的肝癌靶向耐药细胞间传播新机制, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=c5d42051150b)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1795512, encodeId=c1c81e9551290, content=<a href='/topic/show?id=248e1e1345b' target=_blank style='color:#2F92EE;'>#target#</a>, objectTitle=Signal Transduct Target Ther：山东大学王培会教授团队阐明了28个新冠病毒蛋白的亚细胞定位, objectType=article, longId=203582, objectId=347e203582ea, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=347e203582ea, replyNumber=0, likeNumber=36, createdTime=2021-07-16, rootId=0, userName=闆锋旦, userId=8409354, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=347e203582ea, moduleTitle=Signal Transduct Target Ther：山东大学王培会教授团队阐明了28个新冠病毒蛋白的亚细胞定位, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=347e203582ea)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1795515, encodeId=0f9e1e955151d, content=<a href='/topic/show?id=248e1e1345b' target=_blank style='color:#2F92EE;'>#target#</a>, objectTitle=Signal Transduct Target Ther:口服小檗碱改善帕金森, objectType=article, longId=209567, objectId=fa3920956eac, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=fa3920956eac, replyNumber=0, likeNumber=48, createdTime=2021-04-20, rootId=0, userName=闆锋旦, userId=8409354, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=fa3920956eac, moduleTitle=Signal Transduct Target Ther:口服小檗碱改善帕金森, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=fa3920956eac)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1795513, encodeId=154f1e955137b, content=<a href='/topic/show?id=248e1e1345b' target=_blank style='color:#2F92EE;'>#target#</a>, objectTitle=Signal Transduct Target Ther ：突破！向宽辉/童贻刚/周乙华/施一合作首次发现母乳可有效阻断新冠病毒感染, objectType=article, longId=203795, objectId=0a09203e95e0, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=0a09203e95e0, replyNumber=0, likeNumber=43, createdTime=2021-07-27, rootId=0, userName=闆锋旦, userId=8409354, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=0a09203e95e0, moduleTitle=Signal Transduct Target Ther ：突破！向宽辉/童贻刚/周乙华/施一合作首次发现母乳可有效阻断新冠病毒感染, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=0a09203e95e0)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1795511, encodeId=4c251e955114e, content=<a href='/topic/show?id=248e1e1345b' target=_blank style='color:#2F92EE;'>#target#</a>, objectTitle=Signal Transduction and Targeted Therapy: **皮质类固醇激素疗法对2019-nCoV严重肺炎的潜在益处, objectType=article, longId=190773, objectId=f969190e73f3, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=f969190e73f3, replyNumber=0, likeNumber=47, createdTime=2020-10-13, rootId=0, userName=闆锋旦, userId=8409354, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=f969190e73f3, moduleTitle=Signal Transduction and Targeted Therapy: **皮质类固醇激素疗法对2019-nCoV严重肺炎的潜在益处, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=f969190e73f3)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1795509, encodeId=fe331e9550918, content=<a href='/topic/show?id=248e1e1345b' target=_blank style='color:#2F92EE;'>#target#</a>, objectTitle=Onco Targets Ther：丹参醇通过调节PI3K-AKT信号通路抑制肝癌细胞的生长、迁移和侵袭, objectType=article, longId=157025, objectId=365f15e02583, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=365f15e02583, replyNumber=0, likeNumber=61, createdTime=2019-04-27, rootId=0, userName=闆锋旦, userId=8409354, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=365f15e02583, moduleTitle=Onco Targets Ther：丹参醇通过调节PI3K-AKT信号通路抑制肝癌细胞的生长、迁移和侵袭, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=365f15e02583)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1795510, encodeId=77c21e95510c1, content=<a href='/topic/show?id=248e1e1345b' target=_blank style='color:#2F92EE;'>#target#</a>, objectTitle=SCI 正式收录STTT《Signal Transduction and Targeted Therapy》, objectType=article, longId=157701, objectId=434115e701b4, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=434115e701b4, replyNumber=0, likeNumber=49, createdTime=2019-01-21, rootId=0, userName=闆锋旦, userId=8409354, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=434115e701b4, moduleTitle=SCI 正式收录STTT《Signal Transduction and Targeted Therapy》, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=434115e701b4)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1795507, encodeId=3c571e955077b, content=<a href='/topic/show?id=248e1e1345b' target=_blank style='color:#2F92EE;'>#target#</a>, objectTitle=Oncotarget：司美替尼药物组合治疗葡萄膜黑色素瘤, objectType=article, longId=139275, objectId=a4201392e56f, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=a4201392e56f, replyNumber=0, likeNumber=56, createdTime=2018-10-09, rootId=0, userName=闆锋旦, userId=8409354, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=a4201392e56f, moduleTitle=Oncotarget：司美替尼药物组合治疗葡萄膜黑色素瘤, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=a4201392e56f)], followStatus=false, userIsMember=false, type=1, lengthMark=0)] 梅斯话题小助手

target

2020-05-29

闆锋旦 (审核中...)

前往app查看评论内容

#target#

Signal Transduct Target Ther：人脐带血间充质干细胞治疗银屑病

2022-09-06

闆锋旦 (审核中...)

前往app查看评论内容

#target#

Target Oncol:FLAURA中国研究表明一线奥希替尼治疗较吉非替尼改善中国人群EGFR突变NSCLC患者的预后

2022-07-11

闆锋旦 (审核中...)

前往app查看评论内容

#target#

Target Oncol:真实世界评估阿比特龙+泼尼松或泼尼松龙(AAP)一线或二线治疗转移性去势抵抗前列腺癌(mCRPC)的疗效和安全性

2022-12-30

闆锋旦 (审核中...)

前往app查看评论内容

#target#

Signal Transduct Target Ther：研究揭示人脐带间充质干细胞治疗银屑病的疗效及机制

2022-11-05

闆锋旦 (审核中...)

前往app查看评论内容

#target#

Target Oncol:评估真实世界中符合和不符合AURA3研究标准患者二线使用奥希替尼治疗的疗效

2022-12-19

闆锋旦 (审核中...)

前往app查看评论内容

#target#

Signal Transduct Target Ther：人脐带间充质干细胞治疗COVID-19患者的安全性如何？

2021-07-18

闆锋旦 (审核中...)

前往app查看评论内容

#target#

Target Oncol:真实世界探索Crizotinib（克唑替尼）治疗ROS1阳性晚期非小细胞肺癌（NSCLC）患者的疗效

2022-07-10

闆锋旦 (审核中...)

前往app查看评论内容

#target#

Target Oncol:吴一龙教授IIIb期研究关注近真实世界中afatinib(阿法替尼)治疗EGFR突变阳性NSCLC患者的疗效

2022-05-03

闆锋旦 (审核中...)

前往app查看评论内容

#target#

Signal Transduct Target Ther：PD-1抑制剂Toripalimab（特瑞普利单抗）联合化疗二线治疗晚期EGFR突变NSCLC一线TKI进展后显示良好抗肿瘤疗效和可控安全性

2022-01-29

闆锋旦 (审核中...)

前往app查看评论内容

#target#

miRNA-34a decreases ovarian cancer cell proliferation and chemoresistance by targeting HDAC1

2022-05-08

闆锋旦 (审核中...)

前往app查看评论内容

#target#

Signal Transduct Target Ther.：治疗慢性疼痛的新发现

2022-01-04

闆锋旦 (审核中...)

前往app查看评论内容

#target#

Lancet Neurology：急性缺血性卒中（BP-TARGET）血管内治疗成功后强化降压的安全性和有效性：一项多中心、开放标签、随机对照试验

2021-07-08

闆锋旦 (审核中...)

前往app查看评论内容

#target#

Signal Transduct Target Ther：浙大蔡秀军团队揭示外泌体介导的肝癌靶向耐药细胞间传播新机制

2021-01-24

闆锋旦 (审核中...)

前往app查看评论内容

#target#

Signal Transduct Target Ther：山东大学王培会教授团队阐明了28个新冠病毒蛋白的亚细胞定位

2021-07-16

闆锋旦 (审核中...)

前往app查看评论内容

#target#

Signal Transduct Target Ther:口服小檗碱改善帕金森

2021-04-20

闆锋旦 (审核中...)

前往app查看评论内容

#target#

Signal Transduct Target Ther ：突破！向宽辉/童贻刚/周乙华/施一合作首次发现母乳可有效阻断新冠病毒感染

2021-07-27

闆锋旦 (审核中...)

前往app查看评论内容

#target#

Signal Transduction and Targeted Therapy: **皮质类固醇激素疗法对2019-nCoV严重肺炎的潜在益处

2020-10-13

闆锋旦 (审核中...)

前往app查看评论内容

#target#

Onco Targets Ther：丹参醇通过调节PI3K-AKT信号通路抑制肝癌细胞的生长、迁移和侵袭

2019-04-27

闆锋旦 (审核中...)

前往app查看评论内容

#target#

SCI 正式收录STTT《Signal Transduction and Targeted Therapy》

2019-01-21

闆锋旦 (审核中...)

前往app查看评论内容

#target#

Oncotarget：司美替尼药物组合治疗葡萄膜黑色素瘤

2018-10-09

科室
- - 订阅+
  - 更多科室
工具
服务